Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011581 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Jungang Lan und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Developmental Biology of Freshwater Fish, Hunan International Joint Laboratory of Animal Intestinal Ecology and Health, Labor…. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, HIV Infections, Lymphoma, Primary Effusion, HIV-1. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation for Outstanding Young Scholars of Hunan Province, Key Research and Development Program of Hunan Province of China.
Abstract (Originalsprache)
Kaposi’s sarcoma-associated herpesvirus (KSHV) is an oncogenic virus consisting of both latent and lytic life cycles. Primary effusion lymphoma (PEL) is an aggressive B-cell lineage lymphoma, dominantly latently infected by KSHV. The latent infection of KSHV is persistent and poses an obstacle to killing tumor cells. Like the "shock and kill" strategy designed to eliminate latent HIV reservoir, methods that induce viral lytic reactivation in tumor latently infected by viruses represent a unique antineoplastic strategy, as it could potentially increase the specificity of cytotoxicity in cancer. Inspired by this conception, we proposed that the induction of KSHV lytic reactivation from latency could be a potential therapeutic stratagem for KSHV-associated cancers. Oxidative stress, the clinical hallmark of PEL, is one of the most prominent inducers for KSHV reactivation. Paradoxically, we found that hydrogen peroxide (H 2 O 2 ) triggers robust cytotoxic effects on KSHV-negative rather than KSHV-positive B lymphoma cells in a dose-dependent manner. Mechanistically, we identified forkhead box protein O1 (FoxO1) and FoxO3 as irrevocable antioxidant defense genes and both of them are upregulated by KSHV latent infection, which is essential for the promoted ROS scavenging in KSHV-positive B lymphoma cells. Pharmacological inhibition or functional knockdown of either FoxO1 or FoxO3 is sufficient to ablate the antioxidant ability and therefore increases the intracellular ROS level that further reverses KSHV from latency to active lytic replication in PEL cells, resulting in tremendous cell death both in vitro and in vivo . Additionally, the elevated level of ROS by inhibiting FoxO proteins further sensitizes PEL cells to ROS-induced apoptosis. Our study therefore demonstrated that the lytic reactivation of KSHV by inhibiting FoxO proteins is a promising therapeutic approach for PEL, which could be further extended to other virus-associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Developmental Biology of Freshwater Fish, Hunan International Joint Laboratory of Animal Intestinal Ecology and Health, Laboratory of Animal Nutrition and Human Health, Hunan Provincial Key Labor…
- Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Tingting Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation for Outstanding Young Scholars of Hunan Province
- Key Research and Development Program of Hunan Province of China
- Science and Technology Program of Hunan Province
- Key R&D Program of Hunan Province
Zitieren
APA
Lan, J., Wang, Y., Yue, S., Xu, D., Li, Y., Peng, X., Hu, J., Ju, E., He, S., & Li, T. (2023). Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011581
Vancouver
Lan J, Wang Y, Yue S, Xu D, Li Y, Peng X, et al. Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011581
BibTeX
@article{Lan2023,
author = {Lan, Jungang and Wang, Yeqing and Yue, Shusheng and Xu, Duo and Li, Yinan and Peng, Xiangyu and Hu, Jiao and Ju, Enguo and He, Shanping and Li, Tingting},
title = {Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011581}
}
EUVIMED